ZNF738
gene geneOn this page
Summary
ZNF738 (zinc finger protein 738, HGNC:32469) is a protein-coding gene on chromosome 19p12, encoding Zinc finger protein 738 (Q8NE65). May be involved in transcriptional regulation.
Predicted to enable ubiquitin-protein transferase activity. Predicted to be involved in protein polyubiquitination. Predicted to be located in nucleus.
Source: NCBI Gene 148203 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 25 total
- MANE Select transcript:
NM_001355237
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32469 |
| Approved symbol | ZNF738 |
| Name | zinc finger protein 738 |
| Location | 19p12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000172687 |
| Ensembl biotype | protein_coding |
| Entrez | 148203 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 nonsense_mediated_decay
ENST00000311015, ENST00000380870, ENST00000594245, ENST00000597492, ENST00000597810, ENST00000683779, ENST00000915175
RefSeq mRNA: 4 — MANE Select: NM_001355237
NM_001355237, NM_001355239, NM_001355240, NM_001355241
CCDS: CCDS86732, CCDS86733, CCDS92573
Canonical transcript exons
ENST00000683779 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001765206 | 21375869 | 21375964 |
| ENSE00003473888 | 21375238 | 21375364 |
| ENSE00003606307 | 21361766 | 21361858 |
| ENSE00003916555 | 21359000 | 21359143 |
| ENSE00003916857 | 21382866 | 21388582 |
Expression profiles
Bgee: expression breadth ubiquitous, 237 present calls, max score 98.19.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.1245 / max 530.2786, expressed in 1619 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 174886 | 11.3733 | 1603 |
| 174885 | 0.4125 | 201 |
| 174887 | 0.3388 | 159 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 98.19 | gold quality |
| secondary oocyte | CL:0000655 | 96.41 | gold quality |
| embryo | UBERON:0000922 | 94.46 | gold quality |
| ganglionic eminence | UBERON:0004023 | 94.46 | gold quality |
| buccal mucosa cell | CL:0002336 | 94.05 | gold quality |
| ventricular zone | UBERON:0003053 | 90.91 | gold quality |
| cortical plate | UBERON:0005343 | 89.11 | gold quality |
| thymus | UBERON:0002370 | 87.05 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.94 | gold quality |
| tibia | UBERON:0000979 | 84.68 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 84.66 | gold quality |
| cerebellar cortex | UBERON:0002129 | 84.61 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 84.50 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.20 | gold quality |
| cerebellum | UBERON:0002037 | 84.05 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 83.90 | gold quality |
| endometrium | UBERON:0001295 | 83.37 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 83.32 | gold quality |
| corpus callosum | UBERON:0002336 | 82.56 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 82.48 | gold quality |
| amniotic fluid | UBERON:0000173 | 82.35 | gold quality |
| adrenal tissue | UBERON:0018303 | 82.09 | gold quality |
| spinal cord | UBERON:0002240 | 81.67 | gold quality |
| ovary | UBERON:0000992 | 81.47 | gold quality |
| endothelial cell | CL:0000115 | 80.98 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 80.76 | gold quality |
| cerebellar vermis | UBERON:0004720 | 80.69 | silver quality |
| ileal mucosa | UBERON:0000331 | 80.45 | gold quality |
| left ovary | UBERON:0002119 | 80.16 | gold quality |
| metanephros | UBERON:0000081 | 80.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.36 |
Regulation
Is transcription factor: no
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp738 | ENSMUSG00000048280 |
| mus_musculus | Zfp457 | ENSMUSG00000055341 |
| mus_musculus | Zfp595 | ENSMUSG00000057842 |
| mus_musculus | Zfp953 | ENSMUSG00000098905 |
| rattus_norvegicus | AABR07009105.1 | ENSRNOG00000053325 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 738 — Q8NE65 (reviewed: Q8NE65)
All UniProt accessions (6): Q8NE65, A0A804HJ59, E9PE46, M0R024, M0R0N2, M0R3I0
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Miscellaneous. Gene prediction based on partial EST data.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NE65-1 | 1 | yes |
| Q8NE65-2 | 2 |
RefSeq proteins (4): NP_001342166, NP_001342168, NP_001342169, NP_001342170 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050752 | C2H2-ZF_domain | Family |
Pfam: PF00096, PF01352
UniProt features (11 total): zinc finger region 7, splice variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NE65-F1 | 61.96 | 0.07 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 47 (showing top):
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN, chr19p12, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_PROTEIN_POLYUBIQUITINATION, LEE_RECENT_THYMIC_EMIGRANT, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, JOHNSTONE_PARVB_TARGETS_3_DN, ZWANG_DOWN_BY_2ND_EGF_PULSE, KIM_MYCN_AMPLIFICATION_TARGETS_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ASH1L_TARGET_GENES, HSD17B8_TARGET_GENES, LHX9_TARGET_GENES
GO Biological Process (2): protein polyubiquitination (GO:0000209), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (4): DNA binding (GO:0003677), ubiquitin-protein transferase activity (GO:0004842), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein ubiquitination | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| nucleic acid binding | 1 |
| ubiquitin-like protein transferase activity | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
388 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF738 | UBALD2 | Q8IYN6 | 434 |
| ZNF738 | CCDC150 | Q8NCX0 | 433 |
| ZNF738 | SPATA31D1 | Q6ZQQ2 | 419 |
| ZNF738 | ZNF781 | Q8N8C0 | 417 |
| ZNF738 | SLC66A2 | Q8N2U9 | 404 |
| ZNF738 | SOWAHB | A6NEL2 | 399 |
| ZNF738 | NKAIN3 | Q8N8D7 | 397 |
| ZNF738 | ZNF200 | P98182 | 392 |
| ZNF738 | CCDC77 | Q9BR77 | 390 |
| ZNF738 | ZNF260 | Q3ZCT1 | 373 |
| ZNF738 | HROB | Q8N3J3 | 373 |
| ZNF738 | TMEM182 | Q6ZP80 | 371 |
| ZNF738 | FAM72B | Q86X60 | 371 |
| ZNF738 | SKIDA1 | Q1XH10 | 367 |
| ZNF738 | ZNF266 | Q14584 | 359 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM28 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF738 | TRIM28 | psi-mi:“MI:0914”(association) | 0.530 |
| ECE1 | ZNF738 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF738 | KRBA1 | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0JPL0, A1L1L7, A7MBI1, A8MT65, B2RXC5, G3X9G7, P0CG31, P21506, P52738, Q02525, Q2KI58, Q2M3W8, Q49AA0, Q4R6J4, Q5FWF6, Q5RB33, Q5RCJ2, Q5RE50, Q5REF1, Q5T5D7, Q5VIY5, Q6V9R5, Q6ZMW2, Q6ZN11, Q6ZNG0, Q86TJ5, Q86XU0, Q8BGV5, Q8N782, Q8N859, Q8N883, Q8N9Z0, Q8NC26, Q8NE65, Q95K49, Q96N20, Q96NG8, Q96NJ3, Q96SR6, Q9BSK1
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
25 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1257 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:21375325:A:T | donor_gain | 1.0000 |
| 19:21359109:C:G | donor_gain | 0.9900 |
| 19:21359142:TGG:T | donor_loss | 0.9900 |
| 19:21359143:GGTGA:G | donor_loss | 0.9900 |
| 19:21359144:G:C | donor_loss | 0.9900 |
| 19:21359144:G:GG | donor_gain | 0.9900 |
| 19:21359145:T:G | donor_loss | 0.9900 |
| 19:21361764:A:AG | acceptor_gain | 0.9900 |
| 19:21361765:G:GG | acceptor_gain | 0.9900 |
| 19:21375232:TTTCA:T | acceptor_loss | 0.9900 |
| 19:21375233:TTCA:T | acceptor_loss | 0.9900 |
| 19:21375236:A:T | acceptor_loss | 0.9900 |
| 19:21375237:G:T | acceptor_loss | 0.9900 |
| 19:21375864:ATCAG:A | acceptor_loss | 0.9900 |
| 19:21375865:TCAGG:T | acceptor_loss | 0.9900 |
| 19:21375866:CAGGT:C | acceptor_loss | 0.9900 |
| 19:21375867:A:G | acceptor_loss | 0.9900 |
| 19:21359130:G:GT | donor_gain | 0.9800 |
| 19:21361628:AT:A | donor_gain | 0.9800 |
| 19:21361760:CCATA:C | acceptor_loss | 0.9800 |
| 19:21361761:CATA:C | acceptor_loss | 0.9800 |
| 19:21361762:ATAGG:A | acceptor_loss | 0.9800 |
| 19:21361763:TA:T | acceptor_loss | 0.9800 |
| 19:21361765:G:T | acceptor_loss | 0.9800 |
| 19:21361854:AAAAG:A | donor_loss | 0.9800 |
| 19:21361855:AAAGG:A | donor_loss | 0.9800 |
| 19:21361856:AAG:A | donor_loss | 0.9800 |
| 19:21361857:AGGTA:A | donor_loss | 0.9800 |
| 19:21361858:GGTA:G | donor_loss | 0.9800 |
| 19:21361859:GT:G | donor_loss | 0.9800 |
AlphaMissense
2502 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:21375271:T:C | F44L | 0.975 |
| 19:21375273:C:A | F44L | 0.975 |
| 19:21375273:C:G | F44L | 0.975 |
| 19:21375272:T:C | F44S | 0.956 |
| 19:21375250:T:C | F37L | 0.942 |
| 19:21375252:T:A | F37L | 0.942 |
| 19:21375252:T:G | F37L | 0.942 |
| 19:21375309:G:C | Q56H | 0.917 |
| 19:21375309:G:T | Q56H | 0.917 |
| 19:21375358:T:C | F73L | 0.913 |
| 19:21375360:C:A | F73L | 0.913 |
| 19:21375360:C:G | F73L | 0.913 |
| 19:21375342:C:A | N67K | 0.903 |
| 19:21375342:C:G | N67K | 0.903 |
| 19:21375319:T:G | Y60D | 0.898 |
| 19:21375272:T:G | F44C | 0.897 |
| 19:21375288:G:C | W49C | 0.891 |
| 19:21375288:G:T | W49C | 0.891 |
| 19:21375286:T:A | W49R | 0.889 |
| 19:21375286:T:C | W49R | 0.889 |
| 19:21375296:T:C | L52P | 0.871 |
| 19:21375333:G:A | M64I | 0.866 |
| 19:21375333:G:C | M64I | 0.866 |
| 19:21375333:G:T | M64I | 0.866 |
| 19:21375343:T:C | F68L | 0.864 |
| 19:21375345:C:A | F68L | 0.864 |
| 19:21375345:C:G | F68L | 0.864 |
| 19:21375338:A:T | E66V | 0.863 |
| 19:21375308:A:C | Q56P | 0.852 |
| 19:21375353:T:C | L71P | 0.847 |
dbSNP variants (sampled 300 via entrez): RS1000096284 (19:21388998 C>T), RS1000127592 (19:21379368 C>T), RS1000310246 (19:21373045 C>A), RS1000450139 (19:21380919 C>G), RS1000493599 (19:21383972 G>A,T), RS1000610067 (19:21379660 A>G), RS1000698551 (19:21387646 C>T), RS1000773763 (19:21359121 G>A), RS1000888876 (19:21368445 T>C), RS1001020174 (19:21365207 T>A), RS1001048268 (19:21374539 T>C), RS1001109556 (19:21383672 T>A,G), RS1001113691 (19:21367856 T>C), RS1001211642 (19:21378168 T>C), RS1001402320 (19:21363920 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010118_72 | Type 2 diabetes | 2.000000e-13 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, affects expression | 6 |
| bisphenol F | affects cotreatment, decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| potassium chromate(VI) | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| chloropicrin | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Asbestos, Crocidolite | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.